{"public_id":"cl_6d0d841d7bc45892eeb8ca39859be282","status":"active","superseded_by_public_id":null,"corpus_id":205617746,"text":"MTBDRplus had high non-valid result rates on cartridge extracts.","confidence":0.9,"paper":{"corpus_id":205617746,"title":"Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping","url":"https://sah.borca.ai/papers/205617746"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_742d16c4c2a7f1cc57240a0d7e61f560","name":"cartridge extract","description":"Material recovered from used Xpert MTB/RIF cartridges for downstream molecular testing.","types":["sample material"],"url":"https://sah.borca.ai/concepts/co_742d16c4c2a7f1cc57240a0d7e61f560"},{"public_id":"co_998fab217d6db8a6d864e0694c6b0792","name":"MTBDRplus","description":"A molecular line probe assay used for genotypic drug resistance testing.","types":["assay"],"url":"https://sah.borca.ai/concepts/co_998fab217d6db8a6d864e0694c6b0792"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_6d0d841d7bc45892eeb8ca39859be282"}